Ixodes Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • 2ndary - Private

Ixodes General Information

Description

Developer of pharmaceutical products designed to treat tick-borne diseases. The company's products include therapeutic creams which are used as a preventative treatment for tick-borne borreliosis bacteria, as well as used as protection for Lyme disease, enabling patients to get rid of tick and Lyme borne diseases in a hassle-free manner.

Contact Information

Website
www.ixodes.ch
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • Geissacher 10
  • 8126 Zumikon
  • Switzerland

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ixodes Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-Apr-2021 000.00 Completed Generating Revenue
2. Early Stage VC 15-Jun-2012 00.000 000.00 000.00 Completed Generating Revenue
1. Early Stage VC 24-Feb-2011 $16.6M $16.6M 000.00 Completed Generating Revenue
To view Ixodes’s complete valuation and funding history, request access »

Ixodes Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000 00.000000 0000.00 0000.00 00 0000.00 0.000
Ordinary 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
To view Ixodes’s complete cap table history, request access »

Ixodes Patents

Ixodes Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2079441-A1 Topical antibiotic composition for the prevention of lyme disease Active 25-Jul-2007 0000000000
EP-2079441-B1 Topical antibiotic composition for the prevention of lyme disease Active 25-Jul-2007 0000000000 0
ES-2349906-T3 Topical antibiotic composition to prevent lyme disease. Active 25-Jul-2007 0000000000
JP-2010534221-A Topical antibiotic composition for prevention of lyme disease Pending 25-Jul-2007 0000000000
US-8710019-B2 Topical antibiotic composition for the prevention of lyme disease Active 25-Jul-2007 A61K9/0014
To view Ixodes’s complete patent history, request access »

Ixodes Executive Team (3)

Name Title Board Seat Contact Info
Gustave Huber MD President of Board
Luzi von Bidder Chief Financial Officer, Board Member and Economist
You’re viewing 2 of 3 executive team members. Get the full list »

Ixodes Board Members (3)

Name Representing Role Since
Lorenz Werner Self Board Member 000 0000
Yonca Even Self Board Member 000 0000
You’re viewing 2 of 3 board members. Get the full list »

Ixodes Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial